Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients.

  • Authors : Yoshifuji A; Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-Ku, Tokyo, 108-0073, Japan. .; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan. .

Subjects: Renal Dialysis* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jul; Vol. 28 (7), pp. 674-682. Date of Electronic Publication: 2024 Mar 08.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants.

  • Authors : Fryer HA; Allergy and Clinical Immunology Laboratory, Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Hartley GE

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult

  • Source: Journal of clinical immunology [J Clin Immunol] 2023 Oct; Vol. 43 (7), pp. 1506-1518. Date of Electronic Publication: 2023 Jun 16.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.

  • Authors : Hirai K; Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma-cho, Omiya-ku, Saitama-shi, Saitama-ken, 330-8503, Japan. .; Shimotashiro M

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2022 Sep; Vol. 26 (9), pp. 925-932. Date of Electronic Publication: 2022 Apr 15.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

SARS-CoV-2 vaccine-associated subacute thyroiditis.

  • Authors : Yorulmaz G; Faculty of Medicine, Division of Endocrinology and Metabolism, Department of Internal Medicine, Osmangazi University, Eskisehir, Turkey.; Sahin Tekin M

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2022 Jul; Vol. 45 (7), pp. 1341-1347. Date of Electronic Publication: 2022 Feb 19.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

"Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine": comment.

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vasculitis*/Vasculitis*/Vasculitis*/chemically induced

  • Source: Internal and emergency medicine [Intern Emerg Med] 2022 Jun; Vol. 17 (4), pp. 1247. Date of Electronic Publication: 2022 Feb 27.Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine.

  • Authors : Gilio M; Infectious Diseases Unit, San Carlo Hospital, Potenza, Italy. .; De Stefano G

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vasculitis*/Vasculitis*/Vasculitis*/chemically induced

  • Source: Internal and emergency medicine [Intern Emerg Med] 2022 Jun; Vol. 17 (4), pp. 1239-1241. Date of Electronic Publication: 2022 Jan 24.Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis.

  • Authors : Kounis NG; Department of Cardiology, University of Patras Medical School, 7 Aratou Street, Queen Olgas Square, 26221, Patras, Greece. .; Koniari I

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19* ; Hypersensitivity*

  • Source: Journal of clinical immunology [J Clin Immunol] 2022 May; Vol. 42 (4), pp. 736-737. Date of Electronic Publication: 2022 Feb 17.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Internal and emergency medicine [Intern Emerg Med] 2022 Mar; Vol. 17 (2), pp. 481-486. Date of Electronic Publication: 2021 Oct 12.Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study.

  • Authors : Cserep G; East Suffolk & North Essex NHS Foundation Trust, Colchester General Hospital, Turner Rd., Colchester, CO4 5JL, UK.; Morrow D

Subjects: Renal Dialysis*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*prevention & control

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2022 Jan; Vol. 26 (1), pp. 54-58. Date of Electronic Publication: 2021 Jul 29.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment.

  • Authors : Serraino C; Department of Internal Medicine, Santa Croce e Carle' Hospital, Via Michele Coppino 26, Cuneo, Italy.; Melchio R

Subjects: BNT162 Vaccine* ; COVID-19*; COVID-19 Vaccines

  • Source: Internal and emergency medicine [Intern Emerg Med] 2022 Jan; Vol. 17 (1), pp. 311-312. Date of Electronic Publication: 2022 Jan 10.Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  67 results for ""BNT162 Vaccine""